glucagon

Documents about glucagon

• Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease#948171Repositorio de Universidad Autónoma de Chile.
• To Determine Tolerability to Glucagon Infusion in Obese Subjects#966456ClinicalTrials.gov
• Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants#845565ClinicalTrials.gov
• The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes#812461ClinicalTrials.gov
• Postprandial Glucagon Action in the Human Brain#273262Europe PMC
• A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects#908730ClinicalTrials.gov
• Micro Glucagon During Exercise in Type 1 Diabetes#967218ClinicalTrials.gov
• Sitagliptin and Glucagon Counterregulation#256852ClinicalTrials.gov
• The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying#813768ClinicalTrials.gov
• Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism#888360ClinicalTrials.gov
• Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D#915125ClinicalTrials.gov
• Effects of Glucagon-like-Peptide-1 Analogues on Sexuality#865246ClinicalTrials.gov
• Vildagliptin Versus Dapagliflozin on Glucagon#471425ClinicalTrials.gov
• Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes#855565ClinicalTrials.gov
• Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases.#136147PubMed
• Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes#887328ClinicalTrials.gov
• To Evaluate the Response to Glucagon During Hypoglycemia#67816ClinicalTrials.gov
• Glucagon-like Peptide (GLP) Utilization and Safety#668941ClinicalTrials.gov
• Feasibility Trial Testing the Bionic Pancreas With ZP4207#857844ClinicalTrials.gov
• Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes#898714ClinicalTrials.gov
• Association between glucagon-like peptide-1 receptor agonists and colorectal cancer survival: A population-based cohort study#304655HAL (France)
• Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis#827324ClinicalTrials.gov
• Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy#829193ClinicalTrials.gov
• The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis#835410ClinicalTrials.gov
• Incretin Physiology and Beta-cell Function Before and After Weight-loss#850086ClinicalTrials.gov
• Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents#968355ClinicalTrials.gov
• Glucagon in MODY (Maturity Onset Diabetes of the Young)#172469ClinicalTrials.gov
• PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients#226167ClinicalTrials.gov
• GLP_1 RA Ultrasound Study#992051ClinicalTrials.gov
• Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion#915064ClinicalTrials.gov
• CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism#257045ClinicalTrials.gov
• Physiologic Response to Glucagon at Varying Insulin Levels#369943ClinicalTrials.gov
• Effects of Glucagon-Like Peptide-1 Analogs on Sexuality#481698ClinicalTrials.gov
• Assessment of Intranasal Glucagon on Endogenous Glucose Production#812392ClinicalTrials.gov
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone#272289ClinicalTrials.gov
• The Effects of Neprilysin on Glucagon-like Peptide-1#391019ClinicalTrials.gov
• Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis.#645608NCBI PubMed Central
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms#830320ClinicalTrials.gov
• Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World Analysis#241979Europe PMC
• Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus#897750ClinicalTrials.gov
• Paracrine actions of glucagon-like peptide 1 in the gut unraveled#153580HAL (France)
• Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.#311108ClinicalTrials.gov
• The central amygdala gates exogenous glucagon-like peptide 1 signals.#342549NCBI PubMed Central
• Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125#481694ClinicalTrials.gov
• Glucose derived redox equivalents preserve PKA activity and glucagon secretion during hypoglycaemia#991219bioRxiv / medRxiv
• Contribution of Vasoactive Intestinal Peptide to the Depressant Effects of Glucagon-like Peptide-2 on Neurally Induced Contractile Responses in Mouse Ileal Preparations#347970IRIS
• Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery#862930ClinicalTrials.gov
• Protein, Amino Acids & Insulin & Glucagon Secretion in Humans#195488ClinicalTrials.gov
• Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan#377349ClinicalTrials.gov
• Constitutively active glucagon receptor (GCGR) physiologically regulates body temperature in lizards.#479315NCBI PubMed Central